Heiko Jessen

机构：Praxis

发表论文 137 篇 · 总被引 11146 次 · h-index 46

代表论文

• Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial (2020 · The Lancet · 被引 431)
• STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in Germany (2020 · BMC Infectious Diseases · 被引 186)
• Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial (2021 · The Lancet HIV · 被引 91)
• A highly virulent variant of HIV-1 circulating in the Netherlands (2022 · Science · 被引 76)
• Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial (2021 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · 被引 54)
• Barriers to using HIV pre-exposure prophylaxis (PrEP) and sexual behaviour after stopping PrEP: a cross-sectional study in Germany (2021 · BMC Public Health · 被引 50)